|Unit Size||180 capsules|
|Dosage||3â€“6 capsules per day, in divided doses, with meals.|
|Contraindications||If pregnant or lactating, consult your physician before taking this product. L-carnitine and d-ribose have been associated with GI upset, vomiting, heartburn, diarrhea, or headache. Ribose may have a hypo-glycemic effect, which appears to be transient and clinically nonsignificant. It is advised that diabetics be closely supervised by their healthcare provider. Rarely, propionyl-l-carnitine has been associated with muscle weakness and angina. Consult your physician for more information. Carnitine and CoQ10 may be contra-indicated with blood thinning medications. Individuals on anti-hypertensive medications may require blood pressure monitoring. Consult your physician for more information.|
Suggested replacement: CoQ10 l-Carnitine fumarate (120 capsules)
Exercise Support: Propionyl-l-carnitine, acetyl-l-carnitine and l-carnitine fumarate
Cardiovascular Support: Propionyl-l-carnitine and CoQ10
GlycoCarn® is a registered trademark of Sigma-Tau HealthScience and is manufactured under U.S. Patent 6,703,042 and European patent 1,202,956. The combination of GlycoCarn® GPLC and CoQ10 is patented by Sigma-Tau Industries under U.S. Patent 6,814,972. The combination of GlycoCarn® GPLC, l-carnitine and acetyl-l-carnitine is patented under U.S. Patent 6,245, 378.
Use of d-ribose by Pure Encapsulations is authorized by Bioenergy, Inc. under U.S. Patents 4,605,644; 4,719, 201.